======= TGM2 ======= == Gene Information == * **Official Symbol**: TGM2 * **Official Name**: transglutaminase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7052|7052]] * **UniProt**: [[https://www.uniprot.org/uniprot/P21980|P21980]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TGM2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TGM2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/190196|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. |Transglut C| |Transglut core| |Transglut N| |isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine| |isopeptide cross-linking| |peptidyl-glutamine modification| |tube lumen cavitation| |salivary gland cavitation| |negative regulation of endoplasmic reticulum calcium ion concentration| |protein-glutamine gamma-glutamyltransferase activity| |positive regulation of mitochondrial calcium ion concentration| |branching involved in salivary gland morphogenesis| |endoplasmic reticulum calcium ion homeostasis| |mitochondrial calcium ion homeostasis| |salivary gland morphogenesis| |positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway| |salivary gland development| |blood vessel remodeling| |intrinsic component of plasma membrane| |apoptotic cell clearance| |exocrine system development| |peptide cross-linking| |positive regulation of smooth muscle cell proliferation| |phospholipase C-activating G protein-coupled receptor signaling pathway| |gland morphogenesis| |tissue remodeling| |regulation of smooth muscle cell proliferation| |positive regulation of inflammatory response| |tube formation| |morphogenesis of a branching epithelium| |morphogenesis of a branching structure| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of I-kappaB kinase/NF-kappaB signaling| |protein domain specific binding| |positive regulation of cytosolic calcium ion concentration| |peptidyl-lysine modification| |regulation of cytosolic calcium ion concentration| |phagocytosis| |regulation of inflammatory response| |protein homooligomerization| |collagen-containing extracellular matrix| |GTP binding| |positive regulation of cell adhesion| |gland development| |focal adhesion| |morphogenesis of an epithelium| |cellular calcium ion homeostasis| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |positive regulation of defense response| |divalent inorganic cation homeostasis| |protein complex oligomerization| |cellular metal ion homeostasis| |tissue morphogenesis| |positive regulation of response to external stimulus| |metal ion homeostasis| |cellular cation homeostasis| |positive regulation of apoptotic process| |cellular ion homeostasis| |positive regulation of programmed cell death| |tube morphogenesis| |regulation of cell adhesion| |positive regulation of cell death| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |regulation of defense response| |ion homeostasis| |tube development| |peptidyl-amino acid modification| |anatomical structure formation involved in morphogenesis| |cellular homeostasis| |positive regulation of cell population proliferation| |animal organ morphogenesis| |endoplasmic reticulum| |positive regulation of intracellular signal transduction| |regulation of response to external stimulus| |chemical homeostasis| |epithelium development| |mitochondrion| |G protein-coupled receptor signaling pathway| |regulation of response to stress| |regulation of apoptotic process| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of cell population proliferation| |homeostatic process| |positive regulation of signal transduction| |regulation of cell death| |tissue development| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-2| |[[:results:exp483|FTY720 3μM R08 exp483]]|-1.77| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-1.76| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-1.74| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.74| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.71| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.83| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|1.84| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15731 * **Expression level (log2 read counts)**: 2.61 {{:chemogenomics:nalm6 dist.png?nolink |}}